<DOC>
	<DOCNO>NCT03070483</DOCNO>
	<brief_summary>Adequate level vitamin D essential bone health age low level vitamin D may also negatively impact aspect health blood pressure . The investigator previously show adult African ancestry living near equator much high level vitamin D high level blood pressure compare adult African ancestry live Chicago area . Multiple clinical trial examine vitamin D supplementation reduce blood pressure level study focus adult African ancestry low vitamin D level . In addition , previous clinical trial address calcium intake . While vitamin D may modulate blood pressure via action activation renin angiotensin aldosterone system , also possible vitamin D mediate blood pressure via effect gastrointestinal calcium absorption . This pilot study one arm study , assess safety feasibility supplement 15 young adult African ancestry low vitamin D level 5,000 IU Cholecalciferol ( vitamin D3 ) combine 1000 mg elemental calcium daily 3 month . Participants recruit Maywood Illinois surround area flyer brochure . The investigator also contact previous participant Modeling Epidemiologic Study/Vitamin D Ancillary Study phone letter . At baseline , participant blood pressure measure provide fast serum specimen 24-hour urine collection . Calcium , parathyroid hormone level vitamin D measure serum specimen 24-hour urine calcium excretion measure . Repeat visit complete 6 12 week follow-up measure rest blood pressure serum calcium vitamin D level . The overall goal collect pilot data help design large trial vitamin D calcium supplementation lower blood pressure young adult African ancestry .</brief_summary>
	<brief_title>Blood Pressure Blacks Calcium ( BBC ) Vitamin D Study</brief_title>
	<detailed_description>This pilot study recruit 15 black U.S. adult age 25-45 year age 25 ( OH ) D level &lt; 20 ng/ml use anti-hypertensive medication rest seat systolic blood pressure ≥ 120 mmHg measure baseline level total 25 ( OH ) D , 25 ( OH ) D2 , 25 ( OH ) D3 , free vitamin 25 ( OH ) D , active vitamin D [ 1,25 ( OH ) D ] , parathyroid hormone level , serum calcium , 24-hour calcium excretion . Participants take supplement vitamin D3 5000 IU elemental calcium 1000 mg daily three month . Investigators measure change blood pressure , total 25 ( OH ) D , 25 ( OH ) D2 25 ( OH ) D3 , 1,25 ( OH ) D free 25 ( OH ) D , parathyroid hormone level , serum calcium 24-hour urine calcium excretion three month period . The overall goal collect pilot data determine feasibility large trial determine whether vitamin D combine calcium lower blood pressure young black adult low 25 ( OH ) D level . This single arm non-blinded feasibility study 15 participant . The study population consist 15 adult age 25-45 year self-reported African American race/ethnicity . All participant provide write informed consent . Intervention : This study one arm participant receive Cholecalciferol ( vitamin D3 ) 5,000 IU daily 3 month 1000 mg calcium citrate daily 3 month . There placebo blinding agent . Participants receive 3 month supply drug administer Loyola pharmacy . Serum vitamin D calcium level measure study initiation 6 12 week ( study end ) . Participants stop take stop vitamin D calcium administration serum calcium level great equal 10.6 meq/L and/or 25 ( OH ) D level great equal 80 ng/dl 6 week visit . Safety Monitoring : The investigator query hospitalization emergency room visit past month reason visit baseline , 6 12 week follow-up visit . Serum calcium vitamin D level measure 6 12 week anyone serum calcium level ≥ 10.6 meq/L and/or 25 ( OH ) D level ≥ 80 ng/ml stop treatment . All adverse event report Loyola University Chicago Health Sciences Institutional Review Board . A data safety monitor board review data collect completion 6 week visit ensure safety study . Stopping plan : Any participant develops serum calcium level ≥ 10.6 meq/L and/or 25 ( OH ) D level ≥ 80 ng/ml stop treatment continue monitor study week 12 serum calcium 25 ( OH ) D level measure end study . The study continue participant follow 12 week . Analysis Plan : This feasibility study examine multiple aspect pilot data include total number person enrol vs. number total person identify eligible . Pill count do 6 12 week visit ass compliance vitamin D calcium supplementation . The percentage participant take 80 % vitamin D3 supplement calcium supplement determine . The number participant report symptom adverse event quantify . Repeated measure analysis variance model use assess change outcome measure include systolic diastolic blood pressure , vitamin D measure , parathyroid hormone level 24-hour urine calcium excretion value .</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<criteria>1 . Age 2545 year 2 . Selfreported race/ethnicity African American 3 . BMI ≥ 25 kg/m2 4 . Total 25 ( OH ) D level &lt; 20 ng/ml ( 50 nmol/L ) 5 . No use vitamin D supplement within past 30 day screen visit 6 . Able provide write informed consent 7 . Willing take vitamin D supplement daily 3 month 8 . Willing return followup visit measure blood pressure provide blood sample measure vitamin D serum calcium 9 . No current use blood pressure lower medication 10 . Systolic blood pressure ≥ 120 mmHg diastolic blood pressure ≥ 60 mmHg 1 . Medical history chronic disease affect gastrointestinal absorption vitamin D : Crohn 's disease , cystic fibrosis , celiac disease 2 . Use medication may affect total 25 ( OH ) D level : antiepileptic drug , steroid , bile acid sequestrants , lipase inhibitor , orlistat 3 . Current use vitamin D supplement use past month unwillingness discontinue least 1 month prior study enrollment 4 . History kidney stone hypercalciuria 5 . Fasting serum calcium ≥ 10.2 mg/dl 6 . Average systolic blood pressure ≥ 140 mmHg 7 . Average diastolic blood pressure ≥ 90 mmHg 8 . Presence type 1 diabetes mellitus , active malignancy , active thyroid disease sarcoidosis 9 . Pregnant planning pregnancy 10 . Estimated glomerular filtration rate ( base serum creatinine level ) &lt; 60 ml/min/1.73 m2 base Modification Diet Renal Disease formula</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>